Related Experiment Video
Updated: Jul 21, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Association between metabolic dysfunction-associated steatotic liver disease and pulmonary function: a
Ting Feng1, Jiaming Li2, Lihao Wu1
1Department of Gastroenterology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, PR China.
This study found no causal link between metabolic dysfunction-associated steatotic liver disease (MASLD) and reduced pulmonary function. Research confirms MASLD does not cause respiratory issues like COPD or asthma.
Area of Science:
- Hepatology
- Pulmonology
- Genetics
Background:
- Hepatic steatosis is linked to respiratory diseases, but the causal relationship with metabolic dysfunction-associated steatotic liver disease (MASLD) is debated.
- Previous studies suggest a connection, but robust evidence establishing causality is lacking.
Purpose of the Study:
- To investigate the causal association between MASLD and pulmonary function using a large national cohort.
- To employ Mendelian randomization (MR) to assess the etiological link between MASLD and respiratory health.
Main Methods:
- Utilized data from 30,442 participants in the National Health and Nutrition Examination Survey (2007-2012).
- Collected demographics, pulmonary function indices (FEV1, FVC), and liver fat score (LFS) data.
- Performed two-sample MR analysis using GWAS data for MASLD, FEV1/FVC, COPD, and asthma.
Main Results:
- No significant differences in FEV1, FVC, or FEV1/FVC ratio were observed between participants with and without MASLD.
- MR analysis indicated no causal correlation between MASLD and FEV1/FVC, COPD, or asthma.
- Reverse MR analyses also showed no significant causal relationships.
Conclusions:
- This study provides strong evidence against a causal association between MASLD and impaired pulmonary function.
- The findings suggest that MASLD is unlikely to be a direct cause of respiratory diseases such as COPD or asthma.
More Related Videos
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test